<DOC>
	<DOCNO>NCT00182845</DOCNO>
	<brief_summary>The purpose study evaluate feasibility use Donepezil prevent post-operative cognitive decline ( POCD ) among individual age 65 old baseline mild cognitive impairment ( MCI ) undergo elective hip knee replacement .</brief_summary>
	<brief_title>Donepezil Prevention Post-Operative Cognitive Decline</brief_title>
	<detailed_description>Up 65 % elderly patient undergo hip knee surgery suffer decline brain function know post-operative cognitive decline ( POCD ) . These individual often stay hospital long , complication , likely die . Recent clinical study show potential benefit enhance cholinergic system among patient Alzheimer 's disease / vascular dementia . Donepezil currently use treat memory loss patient Alzheimer 's disease . This study recruit 30 cognitively impaired adult age 65 old schedule elective hip knee replacement surgery University Hospital . Participants randomize receive either three six week supply Donepezil match placebo approximately 4 week prior surgery . This study evaluate effect Donepezil delirium incidence severity hospitalization , global cognitive function , length hospitalization , site discharge , adverse drug effect . All material collect interview , questionnaire , medical chart review . Some baseline , hospitalization , 12 week post hospitalization others daily hospitalization . The International Study Post-Operative Cognitive Decline battery test use assessment , CogHealth computerize battery .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Communitydwelling individual age 65 old Scheduled elective hip knee replacement University Hospital Mild cognitive impairment , define : MMSE total score 27 less ; normal performance activity daily live task Bristol scale exclude mobility related difficulty ; chartbased dementia diagnosis ; history ever dementia medication Memantine cholinesterase inhibitor Consent participate study Chartbased dementia diagnosis MMSE score great 27 Difficulty perform activity daily live relate mobility measure Bristol scale Current past history receive dementia medication Memantine cholinesterase inhibitor ( Tacrine , Donepezil , Rivastigmine , Galantamine ) Metastatic cancer comorbid illnesses likely reduce life expectancy 6 month Multiple trauma pathological fracture require acute hip knee replacement Aphasic , blind , deaf Use neuroleptic one month prior surgery Allergy donepezil Inability read complete study test form Alcohol drug dependence , define intake 5 unit alcohol daily past 3 month Not expect discharged hospital able complete 3month postoperative test Not competent make medical decision</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>dementia</keyword>
	<keyword>MCI</keyword>
	<keyword>Aricept</keyword>
	<keyword>Adverse Effects</keyword>
	<keyword>Hospital Acquired Complications</keyword>
	<keyword>Cognitive Impairment</keyword>
	<keyword>Aging</keyword>
</DOC>